DE69629674D1 - Dns-sequenzen des humanen cytomegaloviruses - Google Patents

Dns-sequenzen des humanen cytomegaloviruses

Info

Publication number
DE69629674D1
DE69629674D1 DE69629674T DE69629674T DE69629674D1 DE 69629674 D1 DE69629674 D1 DE 69629674D1 DE 69629674 T DE69629674 T DE 69629674T DE 69629674 T DE69629674 T DE 69629674T DE 69629674 D1 DE69629674 D1 DE 69629674D1
Authority
DE
Germany
Prior art keywords
dna sequences
human cytomegalovirus
hcmv
sequences
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69629674T
Other languages
English (en)
Other versions
DE69629674T2 (de
Inventor
Richard Spaete
Tai-An Cha
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MedImmune Vaccines Inc
Original Assignee
MedImmune Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MedImmune Vaccines Inc filed Critical MedImmune Vaccines Inc
Application granted granted Critical
Publication of DE69629674D1 publication Critical patent/DE69629674D1/de
Publication of DE69629674T2 publication Critical patent/DE69629674T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
DE69629674T 1995-03-31 1996-03-26 Dns-sequenzen des humanen cytomegaloviruses Expired - Lifetime DE69629674T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/414,926 US5721354A (en) 1995-03-31 1995-03-31 Human cytomegalovirus DNA sequences
US414926 1995-03-31
PCT/US1996/004100 WO1996030387A1 (en) 1995-03-31 1996-03-26 Novel human cytomegalovirus dna sequences

Publications (2)

Publication Number Publication Date
DE69629674D1 true DE69629674D1 (de) 2003-10-02
DE69629674T2 DE69629674T2 (de) 2004-07-08

Family

ID=23643613

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69629674T Expired - Lifetime DE69629674T2 (de) 1995-03-31 1996-03-26 Dns-sequenzen des humanen cytomegaloviruses

Country Status (11)

Country Link
US (7) US5721354A (de)
EP (1) EP0821693B1 (de)
JP (1) JP3658411B2 (de)
AT (1) ATE248184T1 (de)
AU (1) AU706234B2 (de)
CA (1) CA2215328C (de)
DE (1) DE69629674T2 (de)
DK (1) DK0821693T3 (de)
ES (1) ES2206569T3 (de)
PT (1) PT821693E (de)
WO (1) WO1996030387A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721354A (en) * 1995-03-31 1998-02-24 Aviron Human cytomegalovirus DNA sequences
WO2001034623A1 (en) * 1999-11-05 2001-05-17 Human Genome Sciences, Inc. 29 human secreted proteins
FR2762601B3 (fr) * 1997-04-29 1999-06-04 Bio Merieux Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utilisations
FR2762600B1 (fr) * 1997-04-29 1999-11-05 Bio Merieux Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utlisations
WO2000034335A2 (en) * 1998-12-04 2000-06-15 Schering Corporation 'death domain' containing receptors
JP3877894B2 (ja) * 1999-01-13 2007-02-07 三菱電機株式会社 車両用ブラシレス交流発電機
WO2000066155A1 (en) 1999-04-30 2000-11-09 La Jolla Institute For Allergy And Immunology Methods for preventing reactivation of latent virus and controlling virus replication
GB0024283D0 (en) * 2000-10-04 2000-11-15 Inpharmatica Ltd Novel proteins
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US7204990B1 (en) * 2000-11-28 2007-04-17 Medimmune Vaccines, Inc. Attenuation of cytomegalovirus virulence
WO2002077181A2 (en) * 2001-03-22 2002-10-03 Incyte Genomics, Inc. Adenylyl and guanylyl cyclases
AU2003300175A1 (en) * 2002-10-09 2004-05-04 University Of Wales College Of Medicine Hcmv derived immunomodulatory polypeptide
AU2003301148A1 (en) * 2002-12-23 2004-07-22 Vical Incorporated Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
GB0400965D0 (en) * 2004-01-16 2004-02-18 Glaxo Group Ltd Promoter
US8088902B2 (en) 2004-04-05 2012-01-03 The Rockefeller University DNA virus microRNA and methods for inhibiting same
US20080044384A1 (en) * 2004-06-25 2008-02-21 Medlmmune Vaccines, Inc. Recombinant Human Cytomegalovirus And Vaccines Comprising Heterologous Antigens
US20140348863A1 (en) * 2011-10-12 2014-11-27 Alessia Bianchi Cmv antigens and uses thereof
CA3028002A1 (en) 2016-06-27 2018-01-04 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075213A (en) * 1984-07-27 1991-12-24 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US5721354A (en) * 1995-03-31 1998-02-24 Aviron Human cytomegalovirus DNA sequences

Also Published As

Publication number Publication date
US6635477B1 (en) 2003-10-21
DE69629674T2 (de) 2004-07-08
US20060240446A1 (en) 2006-10-26
WO1996030387A1 (en) 1996-10-03
US5925751A (en) 1999-07-20
JP3658411B2 (ja) 2005-06-08
AU5372796A (en) 1996-10-16
US5721354A (en) 1998-02-24
PT821693E (pt) 2004-01-30
JPH11503013A (ja) 1999-03-23
EP0821693A4 (de) 1999-09-08
US6040170A (en) 2000-03-21
CA2215328C (en) 2011-05-31
US6291236B1 (en) 2001-09-18
US7208165B2 (en) 2007-04-24
DK0821693T3 (da) 2003-12-22
EP0821693B1 (de) 2003-08-27
ES2206569T3 (es) 2004-05-16
AU706234B2 (en) 1999-06-10
ATE248184T1 (de) 2003-09-15
US20040001850A1 (en) 2004-01-01
CA2215328A1 (en) 1996-10-03
EP0821693A1 (de) 1998-02-04

Similar Documents

Publication Publication Date Title
ATE248184T1 (de) Dns-sequenzen des humanen cytomegaloviruses
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
TR200806258T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
AP2001002199A0 (en) Novel streptococcus antigens
BG103977A (en) Low molecular rotamase enzymic activity inhibitors
TR199901571T2 (xx) T�berk�lozun imm�noterapi te�hisi i�in bile�ikler ve y�ntemler.
DE69323019T2 (de) Verbesserter Nachweis von Mikroorganismen
DE59809260D1 (de) Verfahren zur Herstellung von niedermolekularen Homopolymerisaten des N-Vinylpyrrolidons
NZ304570A (en) Neurone-restrictive silencer factor proteins, nucleic acids and antibodies thereto
NZ504669A (en) Virulence-associated nucleic acid sequences and uses in identification of anti-virulence agents
AU1870597A (en) Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
IL92956A0 (en) Gene sequences which encode acylpeptide hydrolase and methods for detecting cancer utilizing the same
DK0882132T3 (da) Et kombineret humant cytomegalovirus-antigen og anvendelse heraf
MX9806041A (es) Proteina purificada sr-p70.
IL98273A0 (en) Dna sequences,proteins having esterase activity coded by them,and use of such proteins
ATE315092T1 (de) Acetylhydrolase des plättchen aktivierenden faktors, und entsprechendes gen
SE9602822D0 (sv) New receptor
DE69736779D1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
CA2245545A1 (en) Vaccines against varicella zoster virus gene 63 product
AU8156594A (en) Non-A non-B sequences
ES2165358T3 (es) Utilizaciones de la proteinquinasa de neurofilamento/tau pk40.
ATE376586T1 (de) Ppgpp-synthetase und expressionssysteme zur verbesserten herstellung von proteinen
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
DE60024977D1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
CA2177600A1 (fr) Sequences d'acides nucleiques regulatrices et utilisations

Legal Events

Date Code Title Description
8364 No opposition during term of opposition